Trials / Terminated
TerminatedNCT02059252
Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold
Proof of Concept Study Assessing Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Smart Matrix Limited · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
SmartMatrix™ is a single layer dermal replacement scaffold for full thickness skin replacement. The scaffold consists of a porous matrix of cross-linked human fibrin plus alginate that has been designed and optimised to facilitate wound closure and healing through cellular ingress and rapid growth of new blood vessels. This proof of concept study will involve patients with surgical wounds resulting from the excision of basal cell carcinoma (BCC) and squamous cell carcinoma SCC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SmartMatrix dermal replacement scaffold | SmartMatrix dermal replacement scaffold |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2014-02-11
- Last updated
- 2016-04-04
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02059252. Inclusion in this directory is not an endorsement.